MEDIXA PHARMA
Enterprise number 0849178283 · Active (000 Normale toestand)
MEDIXA PHARMA is a besloten vennootschap registered in Lierneux, Belgium, incorporated on 1 Oct 2012. Its registered activity is overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering.
Company details
- Enterprise number
- 0849178283 · official register
- Status
- 000 Normale toestand
- Legal form
- Besloten Vennootschap
- Incorporated
- 1 Oct 2012 (14 years)
- Registered address
- 4990 Lierneux
- Province
- Liège
- Activity
- 70220 Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
- Industry
- Head offices; management consultancy
- Accounts overdue
- Yes
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in Liège
- "Devel'up" Faimes
- "VM MANAGEMENT" Dalhem
- 14 MANAGEMENT Grâce-Hollogne
- 2 the point services Herve
- 2-FLOW Liège
- 21 Liège
- 2ABC Flémalle
- 2D CONSEIL Sprimont
- 2H Invest Liège
- 2N CONSULT Welkenraedt
- 2P MANAGEMENT & CONSTRUCTION Soumagne
- 3 L Consulting Liège
Questions about MEDIXA PHARMA
What is the enterprise number of MEDIXA PHARMA?
MEDIXA PHARMA is registered under enterprise number 0849178283 in the official register of Belgium. View it at the official register.
Is MEDIXA PHARMA still active?
Yes. MEDIXA PHARMA is registered as active (status: 000 Normale toestand).
Has MEDIXA PHARMA gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for MEDIXA PHARMA in the official data.
When was MEDIXA PHARMA founded?
MEDIXA PHARMA was incorporated on 1 Oct 2012.
Where is MEDIXA PHARMA registered?
MEDIXA PHARMA's registered address is in 4990 Lierneux (Liège), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 6 Nov 2026.